Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EP7534 | LA |
lump; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 57-year-old female patient received BNT162b2 (BNT162B2), on 13Mar2021 as dose 1, single (Lot number: EP7534) at the age of 57 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetic" (unspecified if ongoing), notes: Diabetic. Concomitant medication(s) included: METFORMIN taken for diabetes mellitus; AMLODIPINE taken for hypertension; LOSARTAN taken for hypertension; SIMVASTATIN taken for blood cholesterol increased; CETIRIZINE HCL taken for hypersensitivity; FUROSEMIDE taken for fluid retention; OMEPRAZOLE/SODIUM BICARBONATE taken for abdominal discomfort. The following information was reported: INJECTION SITE INJURY (non-serious), outcome "not recovered", described as "lump". Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: The very first shot was very painful thereafter, it really bothered her. There was hard lump that stayed there quite a long time and then the lump traveled a little bit from where first did the shot. Each time she would get Covid shots, lump would go back and forth between her two arms. Clarified, she experienced in lumps in both arms, had shots in both arms.
Medical History/Concurrent Conditions: Diabetic
METFORMIN; AMLODIPINE; LOSARTAN; SIMVASTATIN; CETIRIZINE HCL; FUROSEMIDE; OMEPRAZOLE/SODIUM BICARBONATE
Test Date: 20250926; Test Name: glucose serum stick; Result Unstructured Data: Test Result:234, was high; Comments: Unit: Not Provided; Test Date: 20250926; Test Name: Hemoglobin A1C; Result Unstructured Data: Test Result:9.8, a little high; Comments: Unit: Not Provided